|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/19 | |
| A61K 38/20 | |||
| A61K 35/30 | |||
| C12N 5/074 | |||
| A61P 25/28 | |||
| A61P 25/24 | |||
| A61P 25/16 | |||
| A61P 25/14 | |||
| A61P 9/10 | |||
| A61P 27/06 | |||
| A61P 25/02 |
| (11) | Number of the document | 1765381 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04806493.5 |
| Date of filing the European patent application | 2004-12-29 | |
| (97) | Date of publication of the European application | 2007-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2010-10-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2004/004329 |
| Date | 2004-12-29 |
| (87) | Number | WO 2006/008582 |
| Date | 2006-01-26 |
| (30) | Number | Date | Country code |
| 880101 | 2004-06-30 | US |
| (72) |
SCHAEBITZ, Wolf-Ruediger, DE
SCHNEIDER, Armin, DE
KRUEGER, Carola, DE
SOMMER, Clemens, DE
SCHWAB, Stefan, DE
KOLLMAR, Rainer, DE
MAURER, Martin, DE
WEBER, Daniela, DE
GASSLER, Nikolaus, DE
|
| (73) |
Sygnis Bioscience GmbH & Co. KG,
Im Neuenheimer Feld 515, 69120 Heidelberg,
DE
|
| (54) | TREATMENT OF NEUROLOGICAL DISORDERS WITH HAEMATOPOIETIC GROWTH FACTORS |
| TREATMENT OF NEUROLOGICAL DISORDERS WITH HAEMATOPOIETIC GROWTH FACTORS |